89bio to participate in the 2023 cantor global healthcare conference

San francisco, sept. 20, 2023 (globe newswire) -- 89bio, inc. (nasdaq: etnb), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases, today announced that the company's management will participate in a fireside chat and one-on-one investor meetings at the 2023 cantor global healthcare conference, being held in new york, ny on tuesday, september 26, 2023 at 11:40 am et.
ETNB Ratings Summary
ETNB Quant Ranking